Name Change For Takeda's Dexilant Shows Challenge Of Pre-Market Screening

Sometime after Takeda released its heartburn treatment dexlansoprazole onto the U.S. market in January 2009, it noticed something strange in its post-marketing surveillance: the number of medication errors reported for the drug was not going down